http://newsroom.lilly.com/index.cfm?sh_auth=778643172.0.0.95e50d76e0a0b30f78d045e077bb4c81en-usShareholder.com RSS Feedhttp://newsroom.lilly.com/releasedetail.cfm?ReleaseID=442569Wed, 03 Feb 2010 16:12:00 GMThttp://newsroom.lilly.com/releasedetail.cfm?ReleaseID=442569Lilly's Online, Interactive Health Education Program Receives Two Web Awardshttp://newsroom.lilly.com/releasedetail.cfm?ReleaseID=442413Wed, 03 Feb 2010 13:00:00 GMThttp://newsroom.lilly.com/releasedetail.cfm?ReleaseID=442413Cymbalta(R) Significantly Reduced Chronic Low Back Pain in New Studyhttp://newsroom.lilly.com/releasedetail.cfm?ReleaseID=441003Thu, 28 Jan 2010 11:30:00 GMThttp://newsroom.lilly.com/releasedetail.cfm?ReleaseID=441003Lilly Reports Fourth-Quarter and Full-Year 2009 Resultshttp://newsroom.lilly.com/releasedetail.cfm?ReleaseID=437769Thu, 14 Jan 2010 20:00:00 GMThttp://newsroom.lilly.com/releasedetail.cfm?ReleaseID=437769Lilly CEO Stresses Human Element in Driving Medical Innovationhttp://newsroom.lilly.com/releasedetail.cfm?ReleaseID=437716Thu, 14 Jan 2010 16:34:00 GMThttp://newsroom.lilly.com/releasedetail.cfm?ReleaseID=437716Lilly Sends Relief to Haiti Earthquake Victimshttp://newsroom.lilly.com/releasedetail.cfm?ReleaseID=436294Thu, 07 Jan 2010 21:30:00 GMThttp://newsroom.lilly.com/releasedetail.cfm?ReleaseID=436294Lilly Confirms Date and Conference Call For Fourth-Quarter and Full-Year 2009 Financial Results Announcementhttp://newsroom.lilly.com/releasedetail.cfm?ReleaseID=434208Tue, 05 Jan 2010 14:00:00 GMThttp://newsroom.lilly.com/releasedetail.cfm?ReleaseID=434208New Analysis Showed Effient(R) Cost-Effective Compared with Clopidogrel for Patients with Acute Coronary Syndromes Undergoing PCIhttp://newsroom.lilly.com/releasedetail.cfm?ReleaseID=432443Wed, 23 Dec 2009 15:00:00 GMThttp://newsroom.lilly.com/releasedetail.cfm?ReleaseID=432443Lilly, Kowa and Kowa Pharmaceuticals America Announce Co-Promotion and Licensing Agreementhttp://newsroom.lilly.com/releasedetail.cfm?ReleaseID=431576Mon, 21 Dec 2009 12:30:00 GMThttp://newsroom.lilly.com/releasedetail.cfm?ReleaseID=431576Lilly and Incyte Announce Collaboration for Development and Commercialization of Oral Anti-Inflammatory and Autoimmune Therapieshttp://newsroom.lilly.com/releasedetail.cfm?ReleaseID=431381Fri, 18 Dec 2009 14:00:00 GMThttp://newsroom.lilly.com/releasedetail.cfm?ReleaseID=431381Lilly CFO Derica Rice Assumes Expanded Responsibilities, Promoted to Executive Vice President